N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 18, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

March 23, 2024

Conditions
Biliary Atresia
Interventions
DRUG

N-Acetyl cysteine

Intravenous NAC therapy (6.25 mg/kg/hour of 10 mg/ml solution, or 0.625 ml/kg/hour, to give 150 mg/kg/day), starting within 24 hours of completion of KP and lasting for a total of 7 days

Trial Locations (1)

77030

Texas Children's Hospital and Baylor College of Medicine, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT03499249 - N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy | Biotech Hunter | Biotech Hunter